FOXO TECHNOLOGIES INC. Preferred Stock Dividends, Income Statement Impact
FOXO TECHNOLOGIES INC. (FOXO) reported Preferred Stock Dividends, Income Statement Impact of $112.50 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:PreferredStockDividendsIncomeStatementImpact · last filed 2026-04-15
- FOXO TECHNOLOGIES INC. preferred stock dividends, income statement impact for the quarter ending 2025-12-31 was $0.00.
- FOXO TECHNOLOGIES INC. preferred stock dividends, income statement impact for the quarter ending 2025-09-30 was $56.25K, a 0.00% change year-over-year.
- FOXO TECHNOLOGIES INC. preferred stock dividends, income statement impact for the quarter ending 2025-06-30 was $265.07K, a 14.48% decline year-over-year.
- FOXO TECHNOLOGIES INC. preferred stock dividends, income statement impact for the quarter ending 2025-03-31 was $172.13K, a 73.77% decline year-over-year.
- FOXO TECHNOLOGIES INC. preferred stock dividends, income statement impact for fiscal 2025 was $112.50K, a 100.00% increase from fiscal 2024.
- FOXO TECHNOLOGIES INC. preferred stock dividends, income statement impact for fiscal 2024 was $56.25K, a 98.34% decline from fiscal 2023.
- FOXO TECHNOLOGIES INC. preferred stock dividends, income statement impact for fiscal 2023 was $3.38M.
| Period end | Preferred Stock Dividends, Income Statement Impact 3 month | Preferred Stock Dividends, Income Statement Impact 3 month as first filed | Preferred Stock Dividends, Income Statement Impact 6 month | Preferred Stock Dividends, Income Statement Impact 6 month as first filed | Preferred Stock Dividends, Income Statement Impact 9 month | Preferred Stock Dividends, Income Statement Impact 9 month as first filed | Preferred Stock Dividends, Income Statement Impact 12 month | Preferred Stock Dividends, Income Statement Impact 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $56.25K derived: sum of 2 quarters · filed 2026-04-15 | $321.32K derived: sum of 3 quarters · filed 2026-04-15 | $112.50K 10-K · filed 2026-04-15 | ||||
| 2025-09-30 | $56.25K 10-Q · filed 2025-11-10 | $321.32K derived: sum of 2 quarters · filed 2025-11-10 | $112.50K 10-Q · filed 2025-11-10 | $493.44K derived: sum of 4 quarters · filed 2026-04-15 | ||||
| 2025-06-30 | $265.07K 10-Q · filed 2025-08-19 | $437.19K 10-Q · filed 2025-08-19 | $437.19K derived: sum of 3 quarters · filed 2026-04-15 | $493.44K derived: sum of 4 quarters · filed 2026-04-15 | ||||
| 2025-03-31 | $172.13K 10-Q/A · filed 2025-08-19 | $172.13K derived: sum of 2 quarters · filed 2026-04-15 | $228.38K derived: sum of 3 quarters · filed 2026-04-15 | $538.31K derived: sum of 4 quarters · filed 2026-04-15 | ||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $56.25K derived: sum of 2 quarters · filed 2026-04-15 | $366.19K derived: sum of 3 quarters · filed 2026-04-15 | $56.25K 10-K · filed 2026-04-15 | $1.07M 10-K · filed 2025-04-15 | |||
| 2024-09-30 | $56.25K 10-Q · filed 2025-11-10 | $88.00K 10-Q · filed 2024-11-19 | $366.19K derived: sum of 2 quarters · filed 2025-11-10 | $56.25K 10-Q · filed 2025-11-10 | $1.05M 10-Q · filed 2024-11-19 | $1.02M derived: sum of 4 quarters · filed 2025-11-10 | ||
| 2024-06-30 | $309.94K 10-Q · filed 2025-08-19 | $310.00K 10-Q · filed 2024-08-19 | $966.10K 10-Q · filed 2025-08-19 | $966.00K 10-Q · filed 2024-08-19 | $966.94K derived: sum of 3 quarters · filed 2025-08-19 | $1.88M derived: sum of 4 quarters · filed 2025-08-19 | ||
| 2024-03-31 | $656.16K 10-Q/A · filed 2025-08-19 | $657.00K derived: sum of 2 quarters · filed 2025-08-19 | $1.57M derived: sum of 3 quarters · filed 2025-08-19 | $4.03M derived: sum of 4 quarters · filed 2025-08-19 | ||||
| 2023-12-31 | $834.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $912.83K derived: sum of 2 quarters · filed 2025-04-15 | $3.38M derived: sum of 3 quarters · filed 2025-04-15 | $3.38M 10-K · filed 2025-04-15 | $3.38M 10-K · filed 2024-06-06 | |||
| 2023-09-30 | $912.00K 10-Q · filed 2024-11-19 | $3.38M derived: sum of 2 quarters · filed 2024-11-19 | $3.38M 10-Q · filed 2024-11-19 | $2.47M 10-Q · filed 2024-01-19 | ||||
| 2023-06-30 | $2.47M 10-Q · filed 2024-08-19 | $2.47M 10-Q · filed 2024-08-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |